[HTML][HTML] The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment

EJ van Vuren, SF Steyn, CB Brink, M Möller… - Biomedicine & …, 2021 - Elsevier
The recent outbreak of the corona virus disease (COVID-19) has had major global impact.
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

Glutamate and depression: clinical and preclinical studies

IA Paul, P Skolnick - Annals of the New York Academy of …, 2003 - Wiley Online Library
The past decade has seen a steady accumulation of evidence supporting a role for the
excitatory amino acid (EAA) neurotransmitter, glutamate, and its receptors in depression and …

On the mechanism of antidepressant-like action of berberine chloride

SK Kulkarni, A Dhir - European Journal of Pharmacology, 2008 - Elsevier
Berberine, an alkaloid isolated from Berberis aristata Linn. has been used in the Indian
system of medicines as a stomachic, bitter tonic, antiamoebic and also in the treatment of …

Pharmacogenetics of antidepressant response

S Porcelli, A Drago, C Fabbri, S Gibiino, R Calati… - Journal of Psychiatry and …, 2011 - jpn.ca
Personalized medicine—the adaptation of therapies based on an individual's genetic and
molecular profile—is one of the most promising aspects of modern medicine. The …

Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects

SRL Joca, FS Guimarães - Psychopharmacology, 2006 - Springer
Rationale Systemic inhibition of neuronal nitric oxide synthase (nNOS) induces
antidepressant-like effects in rodents. The mechanisms and brain regions mediating this …

The many faces of nitric oxide in schizophrenia. A review

HG Bernstein, B Bogerts, G Keilhoff - Schizophrenia research, 2005 - Elsevier
Intense research has been conducted in an effort to identify specific biological markers of
schizophrenia. The gas nitric oxide (NO) is one of the most important signaling molecules …

Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes

HA Savas, HS Gergerlioglu, F Armutcu… - The World Journal of …, 2006 - Taylor & Francis
Nitric oxide (NO) has been implicated to play a role in the pathogenesis of many
neuropsychiatric disorders. NO level was found high in acute manic inpatients. In this study …

[HTML][HTML] Neuronal nitric oxide synthase and affective disorders

QG Zhou, XH Zhu, AD Nemes, DY Zhu - IBRO reports, 2018 - Elsevier
Affective disorders including major depressive disorder (MDD), bipolar disorder (BPD), and
general anxiety affect more than 10% of population in the world. Notably, neuronal nitric …

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder

P Gałecki, E Gałecka, M Maes, M Chamielec… - Journal of Affective …, 2012 - Elsevier
BACKGROUND: There is evidence that inflammation, oxidative and nitrosative stress
(IO&NS) play a role in the pathophysiology of depression. There are also data indicating …